中文 | English
Return
Total: 26 , 1/3
Show Home Prev Next End page: GO
MeSH:(Medulloblastoma/pathology)

1.A Result of Treatment of 'Eight Drugs in a Day' in Medulloblastoma: Comparison between Pre- vs Post-Irradiation Chemotherapy.

Hyoung Jin KANG ; Jun Ah LEE ; Hyo Jeong HAN ; Eun Sun YOO ; Hyoung Su CHOI ; Hee Young SHIN ; Sei Won YANG ; Byung Keu CHO ; Chul Woo KIM ; Il Han KIM ; In Won KIM ; Hyo Seop AHN

Korean Journal of Pediatric Hematology-Oncology 1998;5(1):106-112

2.Primitive neuroectodermal tumors in the posterior fossa: excluding medulloblastoma based on pathology.

Kyung Jin SUH ; Tae Hun KIM ; Yong Joo KIM ; Duk Sik KANG ; Sun Young KIM ; Youn Kyung SHON

Journal of the Korean Radiological Society 1992;28(1):149-155

5.A Case of Medullomyoblastoma of Cerebellopontine Angle Mimicking Acoustic Neuroma.

Sang Yoo PARK ; Jin Hyung KIM ; Ki Taek KIM ; Yoo Jung KIM ; Tae Hwan KIM ; Keum HWANG ; Ki Jun SUNG ; Kwang Hwa PARK

Yonsei Medical Journal 2004;45(4):719-722

6.Advances in Understanding the Molecular Biology of Brain Tumors.

John S KUO ; James T RUTKA

Journal of Korean Neurosurgical Society 2004;35(1):1-11

7.Cytologic Features and Distribution of Primary Sites of Malignant Cells in Cerebrospinal Fluid.

Yeon Mee KIM ; Mi Yeong JEON ; Je Geun CHI

Korean Journal of Cytopathology 2000;11(2):65-73

8.Effect of matrine on cell apoptosis and proliferation and the apoptosis related proteins of human medulloblastoma D341 cells in vitro.

Kai-yu ZHOU ; Hai-long JI ; Peng-fei SHI

Chinese Journal of Applied Physiology 2016;32(1):74-77

9.Atypical teratoid/rhabdoid tumors of central nervous system in childhood: a clinical and histopathologic study of 6 cases.

Ying-juan HE ; Zhong-de ZHANG ; Min-zhi YIN ; Xiang-ru WU

Chinese Journal of Pathology 2012;41(4):220-223

10.Clinical Obserbation on Posterior Fossa Tumors.

Suk Keun SHIN

Journal of Korean Neurosurgical Society 1974;3(2):129-142

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 26 , 1/3 Show Home Prev Next End page: GO